| Literature DB >> 24550301 |
Kuan Rong Chan1, Eugenia Z Ong, Hwee Cheng Tan, Summer Li-Xin Zhang, Qian Zhang, Kin Fai Tang, Nivashini Kaliaperumal, Angeline Pei Chiew Lim, Martin L Hibberd, Soh Ha Chan, John E Connolly, Manoj N Krishnan, Shee Mei Lok, Brendon J Hanson, Chao-Nan Lin, Eng Eong Ooi.
Abstract
Viruses must evade the host innate defenses for replication and dengue is no exception. During secondary infection with a heterologous dengue virus (DENV) serotype, DENV is opsonized with sub- or nonneutralizing antibodies that enhance infection of monocytes, macrophages, and dendritic cells via the Fc-gamma receptor (FcγR), a process termed antibody-dependent enhancement of DENV infection. However, this enhancement of DENV infection is curious as cross-linking of activating FcγRs signals an early antiviral response by inducing the type-I IFN-stimulated genes (ISGs). Entry through activating FcγR would thus place DENV in an intracellular environment unfavorable for enhanced replication. Here we demonstrate that, to escape this antiviral response, antibody-opsonized DENV coligates leukocyte Ig-like receptor-B1 (LILRB1) to inhibit FcγR signaling for ISG expression. This immunoreceptor tyrosine-based inhibition motif-bearing receptor recruits Src homology phosphatase-1 to dephosphorylate spleen tyrosine kinase (Syk). As Syk is a key intermediate of FcγR signaling, LILRB1 coligation resulted in reduced ISG expression for enhanced DENV replication. Our findings suggest a unique mechanism for DENV to evade an early antiviral response for enhanced infection.Entities:
Keywords: early innate immune response; immune evasion; innate immune signaling
Mesh:
Substances:
Year: 2014 PMID: 24550301 PMCID: PMC3932915 DOI: 10.1073/pnas.1317454111
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205